BioNexus Gene Lab (BGLC) Competitors $0.38 +0.02 (+5.60%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends BGLC vs. ATIP, TOI, RNLX, PMD, BRTX, MRAI, CNTG, OTRK, VSEE, and CMAXShould you be buying BioNexus Gene Lab stock or one of its competitors? The main competitors of BioNexus Gene Lab include ATI Physical Therapy (ATIP), Oncology Institute (TOI), Renalytix (RNLX), Psychemedics (PMD), BioRestorative Therapies (BRTX), Marpai (MRAI), Centogene (CNTG), Ontrak (OTRK), Vsee Health (VSEE), and CareMax (CMAX). These companies are all part of the "healthcare" industry. BioNexus Gene Lab vs. ATI Physical Therapy Oncology Institute Renalytix Psychemedics BioRestorative Therapies Marpai Centogene Ontrak Vsee Health CareMax ATI Physical Therapy (NYSE:ATIP) and BioNexus Gene Lab (NASDAQ:BGLC) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, earnings, valuation, risk, community ranking, dividends, analyst recommendations, institutional ownership and media sentiment. Do analysts recommend ATIP or BGLC? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ATI Physical Therapy 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/ABioNexus Gene Lab 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Which has more volatility and risk, ATIP or BGLC? ATI Physical Therapy has a beta of 0.41, indicating that its stock price is 59% less volatile than the S&P 500. Comparatively, BioNexus Gene Lab has a beta of 7.7, indicating that its stock price is 670% more volatile than the S&P 500. Which has stronger earnings and valuation, ATIP or BGLC? BioNexus Gene Lab has lower revenue, but higher earnings than ATI Physical Therapy. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioATI Physical Therapy$699.02M0.03-$69.79M-$13.61-0.40BioNexus Gene Lab$9.18M0.74-$2.63MN/AN/A Does the MarketBeat Community prefer ATIP or BGLC? ATI Physical Therapy received 15 more outperform votes than BioNexus Gene Lab when rated by MarketBeat users. CompanyUnderperformOutperformATI Physical TherapyOutperform Votes1536.59% Underperform Votes2663.41% BioNexus Gene LabN/AN/A Is ATIP or BGLC more profitable? ATI Physical Therapy has a net margin of -5.38% compared to BioNexus Gene Lab's net margin of -24.01%. ATI Physical Therapy's return on equity of 0.00% beat BioNexus Gene Lab's return on equity.Company Net Margins Return on Equity Return on Assets ATI Physical Therapy-5.38% N/A -3.96% BioNexus Gene Lab -24.01%-23.07%-19.53% Do institutionals & insiders have more ownership in ATIP or BGLC? 72.6% of ATI Physical Therapy shares are held by institutional investors. Comparatively, 18.9% of BioNexus Gene Lab shares are held by institutional investors. 3.3% of ATI Physical Therapy shares are held by company insiders. Comparatively, 2.0% of BioNexus Gene Lab shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Does the media favor ATIP or BGLC? In the previous week, ATI Physical Therapy had 2 more articles in the media than BioNexus Gene Lab. MarketBeat recorded 2 mentions for ATI Physical Therapy and 0 mentions for BioNexus Gene Lab. BioNexus Gene Lab's average media sentiment score of 1.00 beat ATI Physical Therapy's score of 0.33 indicating that BioNexus Gene Lab is being referred to more favorably in the news media. Company Overall Sentiment ATI Physical Therapy Neutral BioNexus Gene Lab Positive SummaryATI Physical Therapy beats BioNexus Gene Lab on 8 of the 12 factors compared between the two stocks. Ad Crypto 101 MediaCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Click here to reserve your spot at the emergency crypto summit now. Get BioNexus Gene Lab News Delivered to You Automatically Sign up to receive the latest news and ratings for BGLC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BGLC vs. The Competition Export to ExcelMetricBioNexus Gene LabMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.78M$2.57B$5.40B$8.53BDividend YieldN/A1.69%5.15%4.14%P/E RatioN/A30.50112.5515.07Price / Sales0.74190.911,478.8293.55Price / CashN/A507.8339.8334.04Price / Book0.694.414.645.01Net Income-$2.63M-$31.39M$119.13M$225.46M7 Day Performance0.59%1.46%0.78%0.37%1 Month Performance-13.05%-1.36%5.65%3.57%1 Year Performance0.32%35.71%36.90%29.42% BioNexus Gene Lab Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BGLCBioNexus Gene Lab0.9921 of 5 stars$0.38+5.6%N/A+3.9%$6.78M$9.18M0.0030Positive NewsATIPATI Physical Therapy1.6119 of 5 stars$5.78-1.9%N/A-19.3%$25.43M$699.02M-0.425,600Upcoming EarningsShort Interest ↓News CoverageTOIOncology Institute2.3037 of 5 stars$0.33flat$2.50+668.8%-85.7%$24.21M$361.07M-0.41660Gap DownRNLXRenalytix1.2377 of 5 stars$0.21+5.7%$3.00+1,348.6%-79.7%$17.18M$2.29M-0.53100Gap UpPMDPsychemedicsN/A$2.32-0.4%N/A-6.5%$13.47M$20.79M-2.97140Positive NewsHigh Trading VolumeBRTXBioRestorative Therapies4.0457 of 5 stars$1.58-2.5%$18.00+1,039.2%-12.2%$10.70M$174,100.00-0.777Short Interest ↓Positive NewsMRAIMarpaiN/A$0.81+15.8%$6.00+644.9%+76.9%$9.62M$37.15M-0.24150Gap DownHigh Trading VolumeCNTGCentogeneN/AN/AN/AN/A$8.80M$48.54M0.00810Gap UpHigh Trading VolumeOTRKOntrak1.9959 of 5 stars$1.82-7.6%$45.00+2,372.5%-88.7%$7.68M$12.74M-0.05250Gap UpVSEEVsee HealthN/A$1.69-11.5%N/AN/A$6.09M$6.38M0.00N/AGap DownCMAXCareMax3.4828 of 5 stars$1.55-4.3%$45.00+2,803.2%-96.2%$5.90M$784.55M-0.011,450News CoverageGap Up Related Companies and Tools Related Companies ATIP Alternatives TOI Alternatives RNLX Alternatives PMD Alternatives BRTX Alternatives MRAI Alternatives CNTG Alternatives OTRK Alternatives VSEE Alternatives CMAX Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BGLC) was last updated on 11/2/2024 by MarketBeat.com Staff From Our PartnersEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioNexus Gene Lab Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioNexus Gene Lab With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BGLC Stock Alerts